Why the study?
Does a paclitaxel-coated balloon improve angiographic end points compared to a drug-eluting stent in patients undergoing PCI of small coronary vessels?
Does a paclitaxel-coated balloon improve angiographic end points compared to a drug-eluting stent in patients undergoing PCI of small coronary vessels?
The Dior paclitaxel-coated balloon failed to demonstrate equivalence to the Taxus drug-eluting stent for angiographic endpoints in the treatment of small coronary arteries.
Dior PCB failed equivalence to Taxus DES in small-vessel PCI; does not support PCB over DES for this indication.
Dior PCB failed to show equivalence to Taxus DES regarding angiographic end points during PCI of small coronary arteries. CLINICAL TRIAL REGISTRATION NUMBER (EUDRACT CODE): 2009-012268-15.
No takes yet. Share an insight, caveat, or question.
Cortese et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: